Pluristem Therapeutics CEO Zami Aberman's 2018 pay falls 83% to $593K
Pluristem Therapeutics reports 2018 executive compensation
By ExecPay News
Published: April 25, 2019
Pluristem Therapeutics reported fiscal year 2018 executive compensation information on April 25, 2019.
In 2018, three executives at Pluristem Therapeutics received on average a compensation package of $454K, a 81% decrease compared to previous year.
Average pay of disclosed executives at Pluristem Therapeutics
Zami Aberman, Chief Executive Officer, received $593K in total, which decreased by 83% compared to 2017. 88% of Aberman's compensation, or $524K, was in salary. Aberman also received $68K in other compensation.
Yaky Yanay, Chief Executive Officer, received a compensation package of $443K, which decreased by 87% compared to previous year. 94% of the compensation package, or $417K, was in salary.
Erez Egozi, Chief Financial Officer, earned $326K in 2018, a 29% decrease compared to previous year.
Pluristem Therapeutics' fiscal year ends on June 30.
Related executives
You may also like
Source: SEC filing on April 25, 2019.